Dr. Tho Lye Mun Dhakhtar

Dr. Tho Lye Mun wuxuu ka mid yahay dhakhtarka kansarka ugu sareeya ee Kuala Lumpur Malaysia.

Dr Tho Lye Mun wuxuu ku dhamaystay tababarka shahaadada koowaad iyo heerka koowaad ee jaamacadaha Australia iyo Boqortooyada Midowday iyadoo loo marayo barnaamijyada deeqaha waxbarasho ee dibada. Wuxuu uqalmaa Daawada Gudaha (MRCP) wuxuuna heystaa Fellowship of Royal College of Radiologists UK ee Clinical Oncology (FRCR) iyo waliba aqoonsi buuxa oo UK ah. Kadib wuxuu sii waday inuu raadsado xirfad aqoonyahan ah oo takhasus leh oo uu ku qaatay PhD-da maadada kansarka ee hoos timaada barnaamijka sharafta leh ee CRUK / RCR oo weheliya abaalmarino kala duwan oo ay ka mid yihiin abaalmarinta John Paul iyo Abaalmarinta Anne Hollman. Wuxuu ka soo shaqeeyey borofisar ku takhasusay jaamacada Malaya ka hor inta uusan u dhaqaaqin shaqooyinka gaarka loo leeyahay.

Hadda Dr Tho waa ku xigeenka SEAROG (Kooxda Shucaaca Oncology South East Asia) wuxuuna ku firfircoon yahay horumarinta farsamooyinka sare ee shucaaca tusaale. SRS, SBRT/SABR. Sidoo kale waa madaxweyne ku xigeenka LCNM (Shabakadda Kansarka Sambabka ee Malaysia). Dr. Waa afhayeen joogto ah oo lagu martiqaado heer gobol iyo heer caalamiba.
Awards

1. John Paul Award, Ardayda ugu wanaagsan ee PhD, UK
2. Billadaha Anne Hollman, Bulshada Raadiyaha Iskotishka, UK
3. Isbahaysiga Cilmi-baarista Kansarka, Cilmi-baarista Kansarka UK (CRUK) / Royal College of Radiologists, UK
4. Warqadda ugufiican, Kulan cilmiyeed sanadle ah, Kuliyada Royal ee Raajoyaasha, UK
5. Isbahaysiga Cilmi-baarista Kansarka, Machadka Beatson ee Cilmi-baarista Kansarka, Boqortooyada Midowday
6. John Crawford Deeqda Caafimaadka, Australia
7. Deeqaha ASEAN, Singapore

• Gamma mindida iyo Cyberknife SRS
• Qalitaanka Raajada Qalitaanka ee Intracranial (SRS)
• Daaweynta shucaaca jirka ee qalalan (SBRT)
• Qalitaanka Raajada Daaweynta Jirka ee Qalitaanka 'Stereotactic Ablative Body Radio (SABR)'
• Cadaadiska Qaabdhismeedka Radiotherapy (IMRT)
• Raajo daaweyn sawir-haga ah (IGRT)

Kansarka Sambabka. 2019 Oktoobar; 136: 65-73.

Tijaabada Molecular ee kansarka sanbabada ee unugyada aan yareyn ee Malaysia: Bayaanka isafgaradka ee Kulliyada Cudurrada, Akadeemiyada Caafimaadka Malaysia, Malaysiya Thoracic Society, iyo Ururka Oncological Malaysian. Rajadurai P, Cheah PL, Sidee SH, Liam CK, Annuar MAA, Omar N, Othman N, Marzuki NM, Pang YK, Bustamam RSA, Waa LM.

Lancet. 2019 May 4;393(10183):1819-1830.

Pembrolizumab iyo chemotherapy oo aan horey loo daaweyn, PD-L1-muujinta, heer sare ama metastatic kansarka sanbabada ee unugyada yar-yar (KEYNOTE-042): tijaabin, calaamado furan, xakameyn, wajiga 3. Mok et al KEYNOTE-042 Baarayaasha.

Daawada Kansarka. 2015 Aug;4(8):1196-204.

Hawlaha hadda jira ee maaraynta xanuunka kansarka Aasiya: sahan lagu sameeyo bukaanada iyo dhakhaatiirta guud ahaan 10 dal. Kooxda ACHEON, Kim YC, Ahn JS, Calimag MM, Chao TC, Ho KY, Ta LM, Xia ZJ, Ward L, Moon H, Bhagat A.

Aasiyada Baasifiga Aasiya ee Kansarka Kahor. 2015;16(5):1901-6.

Waxyaabaha saadaalinta ee bukaanka qaba kansarka sanbabada unugyada aan yareyn iyo metastases maskaxda: aragtida Malaysia. Tang WH, Alip A, Saad M, Phua VC, Chandran H, Tan YH, Tan YY, Kua VF, Wahid MI, Waa LM.

Kansarka BMC. 2014 Mar 20; 14: 212

Xidhitaanka qaybinta-kansarka adduunka ee adeegyada daryeelka kansarka naasaha ee waddan soo koraya oo dakhli dhexdhexaad ah. Lim GC, Aina EN, Cheah SK, Ismaaciil F, Ho GF, Waa LM, Yip Chet al HPMRS Kooxda Daraasada Kansarka Naasaha.

Daaweynta Bartilmaameedka ah iyo Immunotherapy ee Kansarka Sambabka

www.thestar.com.my/news/nation/2017/11/20/target-therapy-and-immunotherapy-for-lung-cancer

Kordhinta Nidaamkeena Difaaca si loola dagaallamo Kansarka

https://www.star2.com/health/2018/09/05/boosting-immune-system-treat-tumours

Faa'iidaysiga Genome-ka Aadanaha

https://www.nst.com.my/lifestyle/heal/2019/09/520171/profiling-human-genome

Ku Wajahan Kansarka Naasaha

https://www.nst.com.my/lifestyle/heal/2019/10/526132/facing-cancer